1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 van Dongen, M.J.P. Cederberg, A. Carlsson, P. Enerback, S. Wikstrom, M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 296 351 359 10.1006/jmbi.1999.3476 10669593 Solution structure and dynamics of the DNA-binding domain of the adipocyte-transcription factor FREAC-11. 2000 10.2210/pdb1d5v/pdb pdb_00001d5v 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11083.717 S12 TRANSCRIPTION FACTOR (FKH-14) DNA-BINDING DOMAIN 1 man polymer no no MLVKPPYSYIALITMAIQNAPEKKITLNGIYQFIMDRFPFYRENKQGWQNSIRHNLSLNECFVKVPRDDKKPGKGSYWTL DPDSYNMFENGSFL MLVKPPYSYIALITMAIQNAPEKKITLNGIYQFIMDRFPFYRENKQGWQNSIRHNLSLNECFVKVPRDDKKPGKGSYWTL DPDSYNMFENGSFL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo ADIPOSE TISSUE Escherichia sample 9606 Homo sapiens 562 Escherichia coli PLASMID PET-11A database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2000-10-11 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details RCSB Y RCSB 1999-10-12 REL REL HNCA, HN(CO)CA, HNCACB, CACB(CO)NH AND HNCO EXPERIMENTS WERE USED TO OBTAIN SEQUENTIAL ASSIGNMENTS FOR THE BACKBONE. SIDE-CHAIN RESONANCES WERE ASSIGNED USING TOCSY-15N-HSQC, C(CO)NH, H(CCO)NH AND HC(C)H-TOCSY EXPERIMENTS. structures with the lowest energy 125 25 3D_15N-SEPARATED_NOESY 3D_13C-SEPARATED_NOESY HNHA CROSS RELAXATION BETWEEN 13CA-1HA DIPOLAR AND 13C' CHEMICAL SHIFT ANISOTROPY CROSS RELAXATION BETWEEN 13CA-1HA AND 15N-1HN DIPOLAR INTERACTIONS 15 mM 6.1 AMBIENT 300 K THE STRUCTURE WAS DETERMINED FROM 1042 DISTANCE RESTRAINTS, COMPLEMENTED WITH 145 RESTRAINTS ON DIHEDRAL ANGLES AND 36 RESTRAINTS ON HYDROGEN BOND LENGTHS. COMBINED DISTANCE GEOMETRY/SIMULATING ANNEALING PROCEDURE 8 closest to the average 1 MM S12 DBD, 10 MM NACL, 5 MM MGCL2, 0.02% NAN3, 5 MM DTT 1 MM S12 DBD, 10 MM NACL, 5 MM MGCL2, 0.02% NAN3, 5 MM DTT DELAGLIO refinement NMRPipe 1 KRAULIS refinement ANSIG 3.3 BRUNGER structure solution X-PLOR 3.1 800 Varian UNITYPLUS 600 Varian UNITYPLUS 500 Varian UNITYPLUS MET 1 n 1 MET 1 A LEU 2 n 2 LEU 2 A VAL 3 n 3 VAL 3 A LYS 4 n 4 LYS 4 A PRO 5 n 5 PRO 5 A PRO 6 n 6 PRO 6 A TYR 7 n 7 TYR 7 A SER 8 n 8 SER 8 A TYR 9 n 9 TYR 9 A ILE 10 n 10 ILE 10 A ALA 11 n 11 ALA 11 A LEU 12 n 12 LEU 12 A ILE 13 n 13 ILE 13 A THR 14 n 14 THR 14 A MET 15 n 15 MET 15 A ALA 16 n 16 ALA 16 A ILE 17 n 17 ILE 17 A GLN 18 n 18 GLN 18 A ASN 19 n 19 ASN 19 A ALA 20 n 20 ALA 20 A PRO 21 n 21 PRO 21 A GLU 22 n 22 GLU 22 A LYS 23 n 23 LYS 23 A LYS 24 n 24 LYS 24 A ILE 25 n 25 ILE 25 A THR 26 n 26 THR 26 A LEU 27 n 27 LEU 27 A ASN 28 n 28 ASN 28 A GLY 29 n 29 GLY 29 A ILE 30 n 30 ILE 30 A TYR 31 n 31 TYR 31 A GLN 32 n 32 GLN 32 A PHE 33 n 33 PHE 33 A ILE 34 n 34 ILE 34 A MET 35 n 35 MET 35 A ASP 36 n 36 ASP 36 A ARG 37 n 37 ARG 37 A PHE 38 n 38 PHE 38 A PRO 39 n 39 PRO 39 A PHE 40 n 40 PHE 40 A TYR 41 n 41 TYR 41 A ARG 42 n 42 ARG 42 A GLU 43 n 43 GLU 43 A ASN 44 n 44 ASN 44 A LYS 45 n 45 LYS 45 A GLN 46 n 46 GLN 46 A GLY 47 n 47 GLY 47 A TRP 48 n 48 TRP 48 A GLN 49 n 49 GLN 49 A ASN 50 n 50 ASN 50 A SER 51 n 51 SER 51 A ILE 52 n 52 ILE 52 A ARG 53 n 53 ARG 53 A HIS 54 n 54 HIS 54 A ASN 55 n 55 ASN 55 A LEU 56 n 56 LEU 56 A SER 57 n 57 SER 57 A LEU 58 n 58 LEU 58 A ASN 59 n 59 ASN 59 A GLU 60 n 60 GLU 60 A CYS 61 n 61 CYS 61 A PHE 62 n 62 PHE 62 A VAL 63 n 63 VAL 63 A LYS 64 n 64 LYS 64 A VAL 65 n 65 VAL 65 A PRO 66 n 66 PRO 66 A ARG 67 n 67 ARG 67 A ASP 68 n 68 ASP 68 A ASP 69 n 69 ASP 69 A LYS 70 n 70 LYS 70 A LYS 71 n 71 LYS 71 A PRO 72 n 72 PRO 72 A GLY 73 n 73 GLY 73 A LYS 74 n 74 LYS 74 A GLY 75 n 75 GLY 75 A SER 76 n 76 SER 76 A TYR 77 n 77 TYR 77 A TRP 78 n 78 TRP 78 A THR 79 n 79 THR 79 A LEU 80 n 80 LEU 80 A ASP 81 n 81 ASP 81 A PRO 82 n 82 PRO 82 A ASP 83 n 83 ASP 83 A SER 84 n 84 SER 84 A TYR 85 n 85 TYR 85 A ASN 86 n 86 ASN 86 A MET 87 n 87 MET 87 A PHE 88 n 88 PHE 88 A GLU 89 n 89 GLU 89 A ASN 90 n 90 ASN 90 A GLY 91 n 91 GLY 91 A SER 92 n 92 SER 92 A PHE 93 n 93 PHE 93 A LEU 94 n 94 LEU 94 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N VAL 63 A N VAL 63 A O THR 79 A O THR 79 2 A A HG1 H THR LEU 79 80 1.34 2 A A HH O TYR GLN 31 49 1.53 3 A A H O VAL TYR 65 77 1.51 3 A A O HD21 MET ASN 15 19 1.57 3 A A O HE1 ASN TRP 44 48 1.58 3 A A O H ILE THR 10 14 1.59 5 A A HH H TYR ARG 31 53 1.26 5 A A O H ASN SER 55 57 1.50 5 A A HH21 O ARG LYS 67 74 1.57 6 A A HH O TYR GLN 31 49 1.44 7 A A OD1 H ASP ASP 68 69 1.60 8 A A HH O TYR GLN 31 49 1.56 8 A A O HD1 ASN HIS 50 54 1.56 9 A A HD22 HD22 ASN ASN 55 59 1.26 9 A A HE O ARG LYS 67 74 1.50 10 A A HH HE TYR ARG 31 53 1.27 10 A A OD1 H ASP ASP 68 69 1.52 11 A A OD1 HH12 ASN ARG 19 37 1.55 12 A A HH11 H ARG LYS 67 74 1.23 12 A A HH12 HZ1 ARG LYS 67 71 1.32 12 A A O H PRO SER 82 84 1.50 17 A A HH O TYR GLN 31 49 1.50 18 A A O H ASN SER 90 92 1.49 19 A A HG H SER ALA 8 11 1.34 19 A A O H ASP LYS 69 71 1.59 20 A A HD22 HD22 ASN ASN 55 59 1.29 20 A A HH O TYR GLN 31 49 1.40 22 A A O H GLY SER 47 51 1.50 22 A A O H ASP TYR 83 85 1.59 23 A A HH O TYR GLN 31 49 1.59 24 A A HG1 H THR GLY 26 29 1.34 24 A A O HE1 ASN TRP 44 48 1.57 1 A PRO 6 -48.41 -8.03 1 A LEU 56 -69.59 59.00 1 A SER 57 -172.55 -55.64 1 A ARG 67 -72.23 -168.58 1 A PRO 72 -82.18 -157.78 1 A SER 84 -83.54 49.03 1 A MET 87 -69.05 6.15 2 A PRO 5 -42.66 155.57 2 A PRO 82 -50.86 -137.16 3 A PRO 5 -45.58 160.57 3 A PRO 39 -49.75 -7.25 3 A GLN 46 -59.91 -168.89 3 A LYS 74 -82.94 -105.99 3 A PRO 82 -55.12 -141.86 3 A ASP 83 -81.96 45.38 3 A PHE 93 -46.46 -13.76 4 A PRO 6 -73.27 28.79 4 A ARG 67 -79.07 -161.38 5 A PRO 6 -42.25 -12.11 5 A PRO 39 -50.31 -6.07 5 A LEU 56 -65.29 59.21 5 A SER 57 -159.97 -54.87 5 A PRO 66 -71.12 -168.84 5 A PRO 82 -53.25 -79.72 5 A ASP 83 -162.08 42.62 5 A SER 84 -45.37 110.00 5 A TYR 85 -89.95 -76.67 5 A ASN 90 -80.96 44.68 6 A PRO 6 -74.67 27.66 6 A PRO 82 -49.69 -135.99 6 A SER 84 -179.97 44.30 6 A PHE 88 -89.49 35.87 6 A ASN 90 -65.96 1.50 6 A SER 92 -173.47 120.36 7 A PRO 5 -40.93 154.26 7 A PRO 6 -75.72 30.22 7 A PRO 21 -37.33 -73.94 7 A GLU 22 -90.10 -79.97 7 A LYS 23 -165.50 -34.65 7 A LYS 45 -95.55 -66.39 7 A PRO 66 -35.52 162.67 7 A ARG 67 -59.79 -172.36 7 A PRO 72 -47.89 -131.68 8 A PRO 6 -73.40 26.61 8 A PRO 82 -74.55 -153.69 8 A SER 84 -59.30 85.83 8 A PHE 88 -59.15 -107.82 8 A ASN 90 -90.89 31.35 9 A PRO 6 -42.03 -12.17 9 A LYS 70 -49.82 -15.21 9 A ASP 81 -50.84 177.97 9 A PRO 82 -60.87 -145.10 9 A TYR 85 -90.04 -79.41 9 A SER 92 -102.87 -159.60 10 A PRO 6 -74.17 20.93 10 A PRO 39 -49.03 -9.85 10 A LYS 45 -90.41 -78.65 10 A PRO 66 -74.45 -154.26 11 A PRO 5 -44.59 150.26 11 A PRO 39 -45.76 -7.42 11 A GLN 46 -59.07 -118.08 11 A PRO 82 -48.31 -72.15 11 A ASP 83 -157.72 39.77 11 A SER 84 -50.13 89.00 11 A ASN 86 -150.22 29.61 12 A LYS 45 -94.59 -68.33 12 A PRO 66 -45.46 175.90 12 A PRO 82 -66.82 -154.84 12 A ASP 83 -67.69 52.60 13 A PRO 39 -52.11 -3.93 13 A ASN 44 -111.19 77.27 13 A ARG 67 -69.39 -107.53 13 A PRO 72 -41.59 163.75 13 A PRO 82 -79.18 -162.46 13 A ASP 83 -83.35 45.80 13 A PHE 88 -150.03 -139.07 14 A PRO 66 -78.16 -169.49 14 A LEU 80 -103.96 65.65 14 A ASP 81 -152.72 83.50 14 A PRO 82 -57.06 -77.30 14 A ASP 83 -155.64 41.56 15 A PRO 6 -39.79 -23.36 15 A PRO 66 -79.41 -155.87 15 A PRO 82 -59.83 -136.75 15 A SER 84 -81.53 37.78 15 A MET 87 -47.49 173.19 15 A SER 92 -160.38 114.20 16 A PRO 5 -42.52 158.31 16 A GLN 46 -70.43 -160.18 16 A ASP 81 -49.98 173.06 16 A PRO 82 -66.51 -146.13 16 A SER 84 -47.08 99.45 16 A TYR 85 -79.93 -70.04 16 A SER 92 -145.19 -39.65 17 A PRO 6 -45.11 -8.33 17 A ASP 81 -46.73 167.44 17 A PRO 82 -53.98 -145.24 17 A SER 84 1.95 61.75 17 A GLU 89 -57.41 -9.59 18 A PRO 82 -60.87 -141.35 18 A ASP 83 -93.08 31.79 18 A SER 84 -49.57 87.48 18 A ASN 86 -146.52 24.11 18 A ASN 90 -44.16 166.36 18 A PHE 93 -55.57 172.03 19 A LYS 4 -45.98 107.68 19 A PRO 21 -33.60 -84.37 19 A GLU 22 -90.02 -80.05 19 A LYS 23 -159.16 -33.69 19 A PRO 39 -48.45 -6.87 19 A GLN 46 -47.39 -177.95 19 A PRO 66 -45.10 151.09 19 A LYS 70 -70.35 47.42 19 A ASP 81 -48.56 176.68 19 A PRO 82 -66.58 -142.35 19 A SER 84 -54.96 83.43 20 A PRO 6 -39.64 -17.99 20 A PRO 66 -43.63 160.63 20 A PRO 72 -54.83 -145.32 20 A ASP 81 -53.56 174.33 20 A PRO 82 -62.54 -140.07 20 A SER 84 -58.09 75.58 20 A ASN 86 -154.03 82.31 21 A PRO 6 -39.74 -24.36 21 A LEU 80 -74.98 -133.81 21 A PRO 82 -75.17 -145.75 21 A SER 84 -50.48 -7.58 21 A MET 87 -60.70 -155.77 21 A PHE 88 -70.39 -149.95 22 A PRO 21 -38.79 -28.12 22 A PRO 39 -46.68 -7.22 22 A GLN 46 -48.24 177.80 22 A PRO 72 -64.71 13.72 22 A ASP 81 -49.24 175.73 22 A PRO 82 -64.88 -143.51 22 A ASP 83 -95.49 32.03 22 A SER 84 -63.47 67.88 22 A GLU 89 -77.32 -160.71 23 A PRO 66 -42.87 167.61 23 A PRO 82 -83.76 -152.73 23 A MET 87 -48.11 175.15 24 A LYS 24 -79.86 33.13 24 A GLN 46 -61.18 -169.18 24 A PRO 66 -44.63 177.57 24 A PRO 72 -43.96 -10.62 24 A ASP 81 -171.71 73.76 24 A PRO 82 -60.91 -143.33 24 A ASP 83 -88.62 44.59 24 A SER 84 -62.62 71.43 24 A ASN 86 -140.44 31.10 25 A PRO 39 -45.72 -9.44 25 A PRO 72 -73.25 -166.82 25 A LEU 80 -59.69 -121.24 25 A PRO 82 -52.40 -130.11 25 A PHE 88 -62.20 -136.89 SOLUTION STRUCTURE OF THE FORKHEAD DOMAIN OF THE ADIPOCYTE-TRANSCRIPTION FACTOR FREAC-11 (S12) 1 N N A SER 8 A SER 8 HELX_P A ASN 19 A ASN 19 1 1 12 A THR 26 A THR 26 HELX_P A PHE 38 A PHE 38 1 2 13 A PRO 39 A PRO 39 HELX_P A ASN 44 A ASN 44 1 3 6 A GLY 47 A GLY 47 HELX_P A ASN 59 A ASN 59 1 4 13 GENE REGULATION WINGED HELIX, DNA-RECOGNITION HELIX, GENE REGULATION FOXC2_HUMAN UNP 1 Q99958 69 162 1D5V 1 94 Q99958 A 1 1 94 1 ASP conflict MET 1 1D5V A Q99958 UNP 69 1 2 anti-parallel A PHE 62 A PHE 62 A LYS 64 A LYS 64 A TRP 78 A TRP 78 A LEU 80 A LEU 80 1 P 1